• Plant community brand builder PlantX Life Inc. is a growing e-commerce hub with over 5,000 products reflecting its focus on plant-based foods, greenery, textiles, and other items
• The company recently opened a brick-and-mortar store in the San Diego, Calif., area, adding to locations in Venice Beach and the Vancouver, British Columbia area
• The company is preparing to next open stores in Tel Aviv, Israel, and then in a pair of malls in Ontario, near Canada’s legislative capital as part of its international upscaling
• PlantX Life’s weekly podcast series, YouTube channel videos, informative blog and e-commerce portal are a means of providing education on the lifestyle’s benefits not only to fans of plant-based products, but also those who have been reluctant to set foot inside a physical store where vegan items are sold

Plant-based lifestyle e-commerce hub PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) has established a new outlet for its branded products with the grand opening of its new XMarket cafe and store in the San Diego area, joining PlantX’s physical store at Venice Beach (https://ibn.fm/YP7G7). The store has become part of the corporate family begun with the company’s flagship store and dining outlets in the Vancouver, British Columbia area, and will soon be joined by a store and web presence in Tel Aviv, Israel, then retail mall outlets in Toronto and Ottawa, Ontario (https://ibn.fm/2pGxU). The expanding footprint of the company’s XMarket store locations worldwide strengthens PlantX’s aim of diversifying its clientele as it also builds its e-commerce marketplace on a vision of becoming a one-stop shopping destination for the plant-based community, a megalith vegan Amazon. PlantX isn’t simply attempting to build retail channels. The company’s love of vegan and other plant-based interests is leading it to increase public knowledge of the wide spectrum of plant-based products, recipes, and lifestyle benefits, through educational channels such as its weekly podcast, blog and YouTube presence. “In plant-based living, there is a big challenge. For the people who don’t believe in a plant-based lifestyle, right away their back goes up a little bit about even entering into the store or in the environment,” PlantX Founder Sean Dollinger said during a September interview (https://ibn.fm/RYM74). “(XMarket partner) Matthew Kenney, arguably the No. 1 vegan chef in the world, … said it best. He said, ‘Why do you need to point out that it’s plant-based at the end of the day?’ And we’ve put a whole spin now on our markets calling it XMarket,” Dollinger added. “Now that it’s just called XMarket, why would you not go and explore and check it out? … We’ve tried to apply this concept to our e-commerce where (we’re focused on) getting people in the door. Let them just come, let them just try and we know that they’ll be hooked on it.” The blog’s recent entries have addressed topics such as the focus on vitamin B12 in a plant-based diet, the importance of including “superfoods” in meal choices, and non-food topics such as “Plant Variegation 101” and “Plant-Based Slang.” “A healthy body is one that has a healthy digestive system to break down and absorb all the nutrients it receives,” the Oct. 31 entry on tips for improving digestion begins (https://ibn.fm/pZb9v), coinciding with the day when millions of American children collect pre-packaged, sugar-and-fat-loaded candy treats during trick-or-treating. PlantX’s brand ecosystem has already made it a seller of more than 5,000 products in harmony with its love of all things plant-based, and the company aims to continue expanding into cosmetics, clothing and other product brands as well as food services. For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• Events industry and global live streaming, two markets that Friendable’s flagship offering, Fan Pass, can leverage, are expected to grow consistently over the next years
• The Fan Pass Live artist platform has been redesigned, with new apps released on prominent app stores
• Through the platform, artists get the opportunity to earn revenue in numerous ways doing what they love

The events industry was seemingly crippled by the events of 2020. With businesses closing, some permanently, nobody knew when people would be allowed in the same room, let alone a packed concert venue. Despite this, the industry is showing signs of getting back on track, being expected to continue growing over the next few years and reach $1.5 trillion by 2028. This marks a CAGR of 11.2% over the forecast period (2021-2028), up from its 2019 value of $1.1 trillion (https://ibn.fm/ClYa6). While the events industry was slowing down in 2020, the global live streaming market was picking up even more speed, continuing an impressive growing trend. The industry is expected to keep on expanding at an impressive rate, as demand for diverse, quality digital content is only growing. Global live streaming is therefore projected to reach $247.28 billion by 2027, growing at a CAGR of 28.1% (https://ibn.fm/rgNjN). With its unique Fan Pass Live Streaming artist platform, mobile technology and marketing company  Friendable (OTC: FDBL) is uniquely positioned to leverage both these markets and take advantage of their opportunities for growth – appealing to those who want to stay home and watch entertainment and eventually providing the option for exclusive in-person events. Friendable released its flagship offering, Fan Pass, in July 2020 as a platform for artists to share their work and fans to get a front-row seat to the action from the comfort of their home. Since then, the platform has grown considerably, both in terms of number of artist members and fans, as well as in terms of available services and offerings for its users. During the latter part of 2021, the company’s main focus has been to make the Fan Pass platform more visible and accessible. This effort included a redesign of the company’s website, and the launch of new Fan Pass apps on the Apple Store and Google Play. Now, the company is focusing on moving into 2022, offering artists and fans the best that music offers. Artists who sign up with the Fan Pass platform have the opportunity to take advantage of the unique revenue structure available. Artists earn by selling tickets to private events, monthly content views, and the merchandise they offer online. Friendable also sets up monthly contests for the artists to take part in – most recently, Double Down October provided double revenue for those artists who met the qualifications of the contest. Right now, the November contest is underway, and anyone who streamed on or before November 8 was eligible to enter. When becoming an artist on the Fan Pass platform, Friendable offers more than just a place for showcasing talent. The company has also incorporated a streaming gear store and an Artist Pro Services offering. Pro Services allow for artists to create logos, design merchandise, and the material to promote shows on social media platforms. Although these come at a cost, the Fan Pass platform offers three different tiers of products, with prices beginning at under $50. Artists can also enjoy these perks when they join the Fan Pass platform:

• Personal artist channel
• Live streaming and publishing controls
• Customized merchandise
• Custom logo design
• Social media designs
• Artist dashboard
• Maintaining complete control
• Being discovered by new fans

In the future, Friendable will be incorporating other features that will help with artist promotion and their revenue potential as well, such as non-fungible tokens (“NFTs”). Fans who sign up for Fan Pass get exclusive backstage and VIP access to their favorite artists – including a look at their daily lives. The monthly cost to join Fan Pass is less than you would pay for an MP3 download of your favorite song, but this way, you get an entire catalog of artist content at your fingertips. Fans also get access to artist live streams, exclusive merch, the ability to discover new music, and overall more ways to connect with their favorite artists. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• Hedge funds with artificial intelligence capabilities showed competitive edge over investors that didn’t use AI
• Top reason given for using algorithms is to reduce market impact
• The fund offers investment opportunity capitalizing on crypto volatility and powered by proprietary trading algorithms

Artificial intelligence (“AI”) is entering the world of finance — with impressive results. According to a recent “Institutional Investor” article, hedge funds that use AI returned almost triple the global industry average (https://ibn.fm/XoDrA). With that as a backdrop, DigiMax Global’s (CSE: DIGI) (OTC: DBKSF) just-launched Cryptocurrency Hedge Fund could not have come at a better time. “Hedge funds with artificial intelligence capabilities showed a huge competitive edge over investors that didn’t use AI, new research indicates,” the article stated. “AI-led hedge funds produced cumulative returns of 34 percent in the three years through May, a report Tuesday from consulting and research firm Cerulli shows. That compares with a 12 percent gain for the global hedge fund industry over the same period.” The article quoted Justina Deveikyte, associate director of European institutional research at Cerulli: “There has long been suspicion of the ability of AI to react to unexpected events, such as the coronavirus pandemic. . . . “But there is now a sense that the technology has advanced to the point where it is better able to adapt to unforeseen scenarios via the ever-growing amount of market data available.” High volatility has always been part of the investment scene, with most investors understanding that risk. But that doesn’t stop them from looking for ways to lower that risk. A 2020 article released by “The Trade” reported that in an algorithmic trading survey taken before the COVID-19 pandemic, the top reason given for using algorithms is to reduce market impact (https://ibn.fm/SX2X1). “Given the increase in market volatility and trading volumes since March 2020, it is striking that the pandemic has led to a greater realization of algorithmic trading in the industry,” the article observed. “The industry has made positive steps toward beginning to refocus on the quality of execution and achieving better outcomes for the end investor, even though room for improvement remains. Initial concerns brought by The Markets in Financial Instruments Directive (MiFID II) have evolved from managing the compliance requirements particularly around best execution to fine-tuning algorithmic trading strategies as a major component of e-trading usage.” DigiMax’s CryptoCurrency Hedge Fund is representative of DIGI’s expertise in the AI world. The fund offers high net worth, institutional and family office clients a fully systematic long/short active investment into a basket of cryptocurrencies capitalizing on crypto volatility and powered by proprietary trading algorithms (https://ibn.fm/RsS6B). Led by an experienced investment and fund-management team, DigiMax’s actively managed fund provides an excellent opportunity for larger investors to gain exposure to cryptocurrencies in their portfolios. Through the use of CryptoDivine.ai and DigiMax’s artificial intelligence capabilities, investors can take advantage of the high volatility while reducing risk in this new fast-growing asset class. DigiMax is supporting its mission to empower investors to safely invest in cryptocurrencies by harnessing the power of artificial intelligence. The company is committed to unlocking the potential of disruptive technologies by providing advanced financial, predictive, and cryptocurrency solutions across various verticals. DigiMax reveals actionable predictive insight across the financial and human world. For more information, visit the company’s website at www.DigiMax-Global.com. NOTE TO INVESTORS: The latest news and updates relating to DBKSF are available in the company’s newsroom at https://ibn.fm/DBKSF

Date: December 15-16 2021 Online Livestream On December 15-16, 2021, pharma companies, medical vendors, and clinicians are invited to attend the 5th Virtual Clinical Trials conference, the industry’s most trusted and long-lasting conference on clinical trials. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. As clinical trials are switching to more decentralized and hybrid models, a collaborative platform for the exchange of information is vital to keep up with the rapid growth. At the 5th Virtual Clinical Trials Conference, hear from those on the front lines of these remote applications and discuss the future of clinical trials from leading pharma industry stalwarts. At this 2-day event, attendees can learn how to successfully conduct clinal trial operating procedures and protocol design and learn what major obstacles to avoid in data compliance. The speaking faculty consists of an eminent panel of dignitaries and pharma industry professional experts who will offer all-new insights on constructing and measuring endpoints, executing effective patient recruitment strategies, applying innovative technologies, and many other insightful strategies to ensure your next clinical trial is a success. Clinicians, trial managers, clinical data experts, vendors, pharma companies, and scientists should leverage the opportunity offered by the conference. Important topics of discussion include:

• Implement robust trial design techniques and SOPs to improve your internal processes
• Improve patient enrollment, safety monitoring, and follow up outcomes
• Enhance approaches to flexible protocol design in DCTs
• Increase collaboration measures to ensure quality in your decentralized approach
• Understand new and exciting technologies that will increase efficiencies in your trials

Adapt your organization to the virtual change at this 2-day event which will commence in a virtual setting from 8:30 am on 15th December. Attendees will hear how clinical trials are conducted in the European Union (“EU”) and the major changes clinical trials are facing around the globe. Other topics that will be discussed include standardizing safety operating procedures, understanding ways to eliminate duplicate data entry, and how eConsent helps with studies at the site, sponsor, and CROs level to achieve success. For more information, please visit https://ibn.fm/72Oh9.

• InMed Pharmaceuticals has filed an international patent application that specifies a rare cannabinoid that may inhibit or slow the progression of neurodegenerative disease and potentially enhance the neuronal function
• With neurogenerative diseases affecting millions worldwide and the cost of treating patients expected to rise in the future, finding treatments and cures is a matter of increasing urgency
• InMed’s patent application is a promising start, expanding the company’s patent portfolio, which currently includes twelve patent families

InMed Pharmaceuticals (NASDAQ: INM), a global leader in the manufacturing and pharmaceutical development of rare cannabinoids, recently filed a Patent Cooperation Treaty (“PCT”) application, titled “Compositions and Methods for Treating Neuronal Disorders with Cannabinoids” (https://ibn.fm/wIQFy). This international patent application specifies a rare cannabinoid that may inhibit or slow the progression of neurogenerative diseases – such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, and others – by providing neuroprotection in a population of affected neurons. Furthermore, the application demonstrates the cannabinoid can also be used to promote neurite outgrowth, signifying the potential to enhance neuronal function. Dr. Eric Hsu, Senior VP Pre-Clinical Research & Development at InMed, described as encouraging the data demonstrating the potential for using a rare cannabinoid to enhance neuronal function and offer neuroprotection to treat neurodegenerative diseases. “This PCT patent application advances our strategy directed towards researching and developing rare cannabinoids as potential pharmaceutical therapeutics for diseases with high unmet medical needs,” continued Hsu. According to the Harvard NeuroDiscovery Center, 5 million Americans currently suffer from Alzheimer’s Disease, 1 million from Parkinson’s Disease, 400,000 from multiple sclerosis (“MS”), 30,000 from Lou Gehrig’s Disease, and a further 30,000 from Huntington’s Disease. In addition, the center estimates that if left unchecked, three decades from now, more than 12 million Americans will suffer from neurodegenerative diseases, which primarily strike in mid- to late-life (https://ibn.fm/UB26K). Globally, 135 million people are expected to be affected by Alzheimer’s disease alone by 2050, up from 40 million in 2015. Neurodegenerative diseases are also projected to increase the individual, social, and financial burden of taking care of the patients. For instance, the projected economic impact of Alzheimer’s Disease in the United States alone is expected to reach about $1 trillion per year in 2050, according to the 2017 G7 Academies’ Joint Statements (https://ibn.fm/5Tf7a). Based on these factors, the Harvard NeuroDiscovery Center notes that finding treatments and cures is a matter of increasing urgency. InMed’s patent application is, therefore, a promising start. The application expands InMed’s patent portfolio, which currently includes twelve patent families, and demonstrates its commitment to pharmaceutical programs and the potential of rare cannabinoids in medicine. Furthermore, being an international patent law treaty, the PCT provides InMed with a unified procedure for filing patent applications to protect its invention in each of the 153 member countries. Notably, the rare cannabinoid that forms the basis of the PCT is new to InMed’s portfolio. This showcases the company’s continued commitment to researching the therapeutic benefits of rare cannabinoids as well as producing rare cannabinoids for various uses. With more than 140 rare cannabinoids that occur in low amounts in the cannabis plant, InMed observes that the cost of extracting sufficient quantities can be prohibitive. Even so, the company has unparalleled cannabinoid manufacturing expertise, anchored in three manufacturing approaches – biosynthesis, chemical synthesis, and IntegraSyn(TM) (https://ibn.fm/rmxs1) – that gives it complete flexibility to select the most suitable, cost-effective method to produce a high-quality and pure rare cannabinoid fit for the intended purpose. Importantly, BayMedica, InMed’s most recent acquisition, is continuing to develop an expanding library of patentable, new cannabinoid analogs targeting diverse clinical applications. For more information, visit the company’s website at www.InMedPharma.com. NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

• Global cannabis market estimated to reach $19.89 billion in 2021, projected to grow at a CAGR of 27%
• North America projected to record the highest market share during the forecast period
• SGMD is expanding role as a central player in growing California cannabis delivery marketplace, developing in-house cannabis production capacity

As growing numbers of consumers around the world become more aware of the potential benefits of cannabis, the market is projected to see significant growth. A new report notes that the global cannabis market is estimated to grow at a CAGR of 27.0% from 2021 to 2030 (https://ibn.fm/c3OpZ). That anticipated growth has not gone unnoticed by Sugarmade (OTC: SGMD), a product and brand marketing company focused on expanding its end-market access as a central player in the growing California cannabis space. “The global cannabis market has been estimated to reach a value of USD $19.89 billion in 2021 and it is projected to grow at a CAGR of 27.0% during the forecast period,” stated the Quince Market Insights report. “The market growth can be attributed can be attributed to the rising awareness among customers concerning the health advantages of cannabis and its increasing medical application. “The growth factors identified in the market are the proven medicinal effects of cannabis, legalization of cannabis, developments in intellectual property rights of cannabis, and active research and development and modification of the plant,” the article continued. “As the threat and concern of coronavirus continue in communities, the cannabis industry emerges to be growing. The government all around the world are taking initiatives to legalize cannabis because of its numerous medicinal advantages like treatment of chronic diseases is an important factor increasing the development of the cannabis market.” The report categorized the global cannabis market into five main areas: North America, Europe, Asia Pacific, Middle East and Africa, and South America, with North America “projected to record the highest market share during the forecast period. The medical application of cannabis is observing remarkable development as customers are becoming more conscious about the medicinal advantages of cannabis,” the article stated. “According to the U.S. Government Accountability Officer, conditions and symptoms that can be treated by cannabis include Alzheimer’s diseases, HIV-AIDS, anorexia, arthritis, nausea, pain, Crohn’s disease, migraines, and multiple sclerosis. Continuous research and standardization of products for medicinal purposes are anticipated to raise the popularity and demand for cannabis in the future.” Sugarmade has set its eyes on expanding its end-market access as a central player in the growing California cannabis delivery marketplace while also developing its in-house cannabis production capacity to verticalize operations in the space. Through a combination of organic growth and strategic acquisitions, Sugarmade is working to develop a full farm-to-door vertically integrated cannabis business. For more information, visit the company’s website at www.Sugarmade.com. NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SGMD

• Tingo Inc has recently submitted its application to list its shares on the New York Stock Exchange
• The company has sought to increase overall liquidity in their shares and drive shareholder returns
• Peer companies operating within Tingo Inc’s business verticals have enjoyed outstanding returns this year, a testament to the growth in demand for sectors such as e-commerce marketplaces and fintech services

Tingo (OTCQB: IWBB), a digital service agri-fintech technology company focused on foundation-level agriculture and related financial services in Africa, recently revealed that it has applied to list its shares for trading with the New York Stock Exchange (“NYSE”), forming part of the company’s efforts to broaden its appeal to U.S. and international investors. Whilst there are no guarantees that its listing application will be accepted, the Company has reiterated its belief that it will satisfy the NYSE’s initial listing criteria. Dozy Mmobuosi, CEO of Tingo commented regarding the listing application, “I am pleased to announce our plans to list on the New York Stock Exchange. This is an important step forward for Tingo. The NYSE is the main stock exchange the United States and one that will raise our profile to the broader investment community. The bottom-up list will increase liquidity in our stocks and ultimately create shareholder value in line with our international peer groups.” Tingo Inc has based its unique business model around four core pillars, namely – device as a service, mobile voice and data services, the Nwassa Marketplace Platform and Tingo Pay, all of which provide the parent company with exposure to some of the fastest growing sub-sectors within the listed equity universe. However, the African continent’s e-commerce industry still finds itself at a relatively nascent stage; despite being home to a youthful demographic, online retail revenues in Africa accounted for only $20 billion in 2020, equivalent to 3.5% of total retail sales. In absolute terms, that would place the African continent’s e-commerce expenditure below the likes of Australia, despite boasting a population on par with that of China. Tingo Inc’s planned NYSE listing provides global investors with access to a rare and diversified investment opportunity within the African continent, with investors previously constrained when seeking to gain exposure to the latter geography (https://ibn.fm/nLqVp) The company’s prospects however look extremely bright, when compared to its peers; online marketplaces and fintech focused firms have all enjoyed a stellar run thus far this year. South Africa’s MTN Group (JSE: MTN), Africa’s largest mobile operator, has seen its shares appreciate by over 130% year-to-date whilst dLocal (NASDAQ: DLO), a Uruguay-based, emerging markets focused payment platform has seen its shares nearly double since listing in early June, giving the company a market capitalization of over $16 billion. With a stated aim of being into Africa’s leading agri-fintech company, focused on driving financial inclusion, social betterment, and wealth creation within Africa’s agricultural sectors, Tingo Inc ranks amongst the rarest of companies – driving social change whilst simultaneously, boosting shareholder returns. For more information, visit the company’s website at www.TingoGroup.com. NOTE TO INVESTORS: The latest news and updates relating to IWBB are available in the company’s newsroom at https://ibn.fm/IWBB

• The company also secured an investment by BIGG Digital Assets, Inc., a seasoned investor in cryptocurrency future and owner of an already impressive portfolio of companies and minority investments in that field
• The Lightning Network is scalable, global, open, inclusive, permissionless, and decentralized, and uses nodes that are connected through multiple channels that enable off-chain, instantaneous, and cheap payments at scale
• LQwD’s platform makes it easy for businesses, exchanges, and investors, to use the Lightning Network, which offers a viable solution for scaling bitcoin for global microtransactions, designed to reduce transaction fees and improve settlement times
• The network’s current capacity is estimated at over CAD $246.3 million (USD $198 million), with an average node capacity of approximately CAD $13,680 (USD $11,000), and over 29,000 nodes currently active

Financial tech and digital payment company LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF) announced that it secured CAD $8 million (USD $6.4 million) in financing to fund the future expansion of its proprietary Lightning Network Platform, to acquire additional bitcoin as an operating and reserve asset and to cover general corporate and working capital purposes (https://ibn.fm/JJl8x). More specifically, the company closed a previously announced offering of 20 million units at a price of CAD $0.35 (USD $0.28) each with gross proceeds of CAD $7 million (USD $5.6 million). An additional CAD $1,050,000 (USD $845,000) was obtained as a result of the offering’s underwriters, a syndicate led by Canaccord Genuity Corp. and including PI Financial Corp., exercising their over-allotment option and purchasing an additional 3 million units. The financing included LQwD joining the investment portfolio of BIGG Digital Assets Inc. (CSE: BIGG) (OTCQX: BBKCF) (WKN: A2PS9W), a major investor and supporter of cryptocurrency solutions and widespread adoption, following the latter’s investment into the company and its proprietary Lightning Network. BIGG invested CAD $100,000 (USD $80,360) in LQwD, adding it to other recent strategic investments such as WonderFi ($WONDF) and ZenLedger (https://ibn.fm/RNyka). BIGG already owns Netcoins, one of Canada’s leading online cryptocurrency brokerages that makes it easy to buy, sell, and understand cryptocurrency, as well as Blockchain Intelligence Group, a leading developer of blockchain technology search, risk-scoring, and data analytics solutions. “As the crypto market continues to mature and evolve, we believe companies like LQwD will help lead the way in infrastructure and plumbing for crypto payments,” BIGG CEO Mark Binns stated. “Our investment in LQwD shows our support for an established group of entrepreneurs and our continued leadership in the cryptocurrency sector.” Moreover, LQwD entered a strategic services agreement with Netcoins that enables the BIGG company to establish a node on the Lightning Network in what is the first institutional grade Lightning payment channel for both Netcoins and BIGG (https://ibn.fm/8rVqx). Under the agreement, Netcoins will also serve as preferred liquidity provider for LQwD’s virtual currency platform, Coincurve.com, while Blockchain Intelligence Group will provide Coincurve and the Lightning Network with institutional and government grade compliance software. LQwD’s Lightning Network platform-as-a-service allows users to leverage the lightning network infrastructure to send payments instantly, securely, and inexpensively worldwide. The network comprises nodes connected through payment channels, enabling off-chain, instantaneous, and cheap payments at scale. The current Lightning Network capacity is valued at over CAD $246.3 million (USD $198 million), with an average node capacity of approximately CAD $13,680 (USD $11,000) and over 29,000 nodes currently active (https://ibn.fm/u5mWM). These nodes can be monitored and managed with little to no technical expertise required through LQwD’s platform. The Lightning Network was designed as a viable solution for massively scaling bitcoin for global microtransactions. The network dramatically improves on fees and provides instant settlement times. LQwD’s proprietary platform allows users to easily tap into the Lighting Network which offers scalable, global, open, inclusive, permissionless, and decentralized Bitcoin transactions. The network is already built, functioning, and growing, and LQwD sees it as an enabling technology that will bring bitcoin to hundreds of millions of new users worldwide. Even well-known companies such as Twitter and Square have expressed an interest in and enthusiasm about incorporating the Lightning Network into their platforms. By further expanding its lightning Network platform, LQwD can successfully tap into multiple opportunities of the booming cryptocurrency market, which has been growing steadily worldwide over the last few years. The global market was valued at CAD $1.85 billion (USD $1.49 billion) in 2020 and is anticipated to reach CAD $6.14 billion (USD $4.94 billion) by 2030, growing at a CAGR of 12.8% (https://ibn.fm/XTKqk). For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• Plant-based wellness brand builder PlantX Life is expanding its footprint, adding a brick-and-mortar store in San Diego to its flagship store in British Columbia
• PlantX Life celebrated the San Diego store’s grand opening Oct. 30 with a variety of plant-based brand builders, including the popular food innovator Beyond Meat
• The San Diego store has more than 4,500 square feet of retail and café space, as well as an education center with resources for increasing consumer awareness
• PlantX Life’s digital presence includes a weekly podcast series, YouTube channel videos, an informative blog and an e-commerce portal accessible through Walmart’s and Amazon’s marketplaces
• The company intends to open a third store in Israel in November with a website focused on consumers in that part of the world
• PlantX Life’s first year-end financial report in July stated the company’s gross revenues had grown to $6.58 million as of March 31

American multinational food processing and commodities trading giant Archer-Daniels-Midland (“ADM”) recently released its second annual list of global consumer trends, highlighting the plant-based lifestyle in its No. 2 position with a note that COVID-19 “has accelerated interest in plant-based (nutrition), as a health-forward alternative for consumers who are paying close attention to their body’s nutritional needs” (https://ibn.fm/WmpwG). The report by the Big Food corporation followed research showing that 18 percent of alt protein buyers in the United States made their first such purchase after the advent of the pandemic and that 92 percent of those first-time buyers expect to continue purchasing meat alternatives (https://ibn.fm/P1uOz). Relative plant-based ecosystem newcomer PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is growing into a one-stop shopping community brand builder with expectations of capitalizing on the popularity of the plant-based lifestyle, and on Oct. 30 the Canada-based company celebrated the grand opening of its first brick and mortar store in the United States as evidence of its global outlook. “The grand opening event celebrating our XMarket store in (the Hillcrest neighborhood of San Diego, California) is yet another opportunity to increase our company’s profile,” PlantX Founder Sean Dollinger stated (https://ibn.fm/AXmtA). “We are proud of our presence in Hillcrest, and we are eager to serve the local community.” PlantX opened its flagship physical store in Squamish, British Columbia. In addition to the California store, it has acquired a storefront in Tel Aviv, Israel, that will serve as the hub of its activities in that region (https://ibn.fm/NUodQ). The California store’s opening follows the launch of PlantX Life’s XFood delivery service in Southern California, which has been using a ghost kitchen in central Los Angeles since it was announced in July. The new XMarket location has more than 4,500 square feet of retail and café space, as well as an education center displaying a variety of resources such as plant-based recipe cards and videos. In keeping with PlantX’s brand purpose, the retail store will offer high-quality grocery items, cosmetics, wellness products and indoor plants, and the café will feature state-of-the-art equipment and trained baristas. Popular plant-based meat innovator Beyond Meat was among the plant-based brands distributing free product samples at the grand opening, showcasing its registered Beyond Burger as a nutritious and sustainable plant-based option. PlantX is passionately pursuing a mission of becoming the go-to source for all aspects of the plant-based lifestyle with the aim of achieving an Amazon-type ecosystem that promotes consumer wellness and earth-friendly sustainability. The company’s first year-end financial report filed in July stated gross revenues had grown to $6.58 million as of March 31 (https://ibn.fm/LcuQb). For more information, visit the company’s websites at www.PlantX.com, www.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• Pharmacy services developer Avricore Health is building its network of lab-grade testing and reporting for select conditions in an effort to make “actionable health information more accessible for everyone”
• Avricore’s trademarked platform, HealthTab, sustains a growing trend that is counting on community pharmacists to serve their local populations by providing testing to rapidly assess medical conditions
• The HealthTab platform is cooperative with numerous partners to create an end-to-end testing experience
• The company aims to be in 600 locations by the end of 2023, and recently expanded its accessibility by opening five new locations in British Columbia

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is increasing access to the innovations of its walk-in pharmacy diagnostic technology thanks to the company’s expansion from key cities in Canada’s eastern locales to sites on the western seaboard, where Avricore hopes to diversify the profile of patients using its service. The addition of five British Columbia outlets through Avricore’s pilot partnership with nationwide pharmaceutical chain Shoppers Drug Mart is expected to serve as an early booster stage for the company’s plans to serve 600 locations by the end of 2023 (https://ibn.fm/XxX3h). Shoppers Drug Mart’s large networks includes the potential of 1,800 pharmacies across Canada, and between Canada, the U.S., and the U.K., there are opportunities for placement in about 110,000 pharmacies overall. Avricore’s announcement last month included news that it had completed the rollout of its point of care platform for providing lab-quality results regarding pre-diabetes. The platform is trademarked as HealthTab, a communications network that draws on data from blood samples and other fluids gathered at trademarked ID Now kiosks (Abbott Diagnostics) using the Piccolo Xpress chemistry analyzer (Abaxis Global Diagnostics). Avricore’s technology has the flexibility to work with an array of new partners to detect additional medical conditions from additional populations as time progresses, utilizing the professional skills of neighborhood pharmacists to oversee the process and sharing the data with the patient, the patient’s medical providers, and researchers interested in advancing science with the help of the identification-free information. The Pharmaceutical Journal recently noted that community pharmacies in England dispense more than 1 billion prescriptions each year, and yet a significant number of patients may suffer adverse reactions to the drugs or simply find them ineffective, which is giving rise to more service oriented approached, like testing, to establish a more personalized approach to prescriptions suited to patients’ individual capacities to benefit from them. “There are 11,400 community pharmacies in England that are less than a 20-minute walk from home for 89% of people,” the Journal states, citing a Pharmaceutical Services Negotiating Committee report (https://ibn.fm/In07E). “…part of the natural evolution of the role of the community pharmacist, from dispensing medicines to providing an increasing number of clinical pharmacy services. Feasibility was underlined by the fact that the service is comparable to existing community pharmacy services (e.g. the influenza vaccination service) and therefore not too onerous.” A Pharmacy Times report earlier this year on the Pharmacy Development Services (“PDS”) 2021 conference’s discussion of point-of-care testing also cited statistics derived from a group A streptococcal (group A strep) testing program in which 278 out of 316 tested patients were found eligible to gain condition management through their pharmacy, and of that number almost half (44 percent) visited the pharmacy during hours in which a physician’s office would be closed, and 43 percent reported having no primary care provider (https://ibn.fm/Y3MaR). “We’ve demonstrated a unique resilience by remaining focused on our goal of creating the world’s largest rapid testing network in pharmacy,” Avricore Health CEO Hector Bremner stated in a June news release (https://ibn.fm/x303p). “We are well on our way to making actionable health information more accessible for everyone and dramatically expanding our network in the coming months.” For more information, visit the company’s website at www.AvricoreHealth.com. NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF